Navigation Links
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
Date:8/29/2007

NATICK, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European Society of Cardiology Congress 2007, which runs from September 1 to 5 in Vienna, Austria.

The Company plans to announce five-year results from the TAXUS II clinical trial. The data are expected to build on the strong body of clinical evidence supporting the continued efficacy and long-term safety profile of the TAXUS(R) Paclitaxel-Eluting Stent System. In addition, the Company will announce partial one-year data from Phases II and III of the OLYMPIA registry, designed to study real-world outcomes of its TAXUS(R) Liberte(TM) Paclitaxel-Eluting Stent System. The Company anticipates the data will further reinforce the safety and efficacy of its second-generation drug-eluting stent system.

Details of the Company's activities at ESC 2007 are below.

Schedule of events (all times are Vienna time)

Sunday, September 2

-- OLYMPIA Phase II & III one-year data. Preliminary results from Phases

II & III of the global OLYMPIA registry will be presented by Martyn

Thomas, M.D., F.R.C.P., at 4:45 p.m., in the Helsinki Room (Zone 2).

OLYMPIA is a prospective, multi-center, multi-phased registry with a

planned enrollment of up to 27,000 patients, making it the largest

study of its kind worldwide. The registry is designed to analyze real-

world clinical outcomes data for Boston Scientific's second-generation

TAXUS Liberte Paclitaxel-Eluting Stent System. Results from more than

7,000 Phase II and III patients will focus on safety and efficacy, and<
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Announces Schedule for EuroPcr 2007
2. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
7. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Inspire Announces Presentations at Two European Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... novel wearable injector slightly larger than an Oreo cookie may ... prescription drugs in the large doses required to treat a ... and genetic disorders.  An emerging biologic drugs ... to analysts.   Many of these drugs will require a new ...
(Date:1/14/2014)... Jan. 14, 2014 The Brandeis Medical Center, led by Dr. ... a premier and affordable laser tattoo removal experience with the advanced ... is in providing high quality cosmetic services with cutting edge medical ... " Southern California has seen a dramatic increase ...
(Date:1/14/2014)... , Jan. 14, 2014   NuAire , a manufacturer of ergonomically ... with Hitachi Koki of Japan ... North America . NuAire will utilize its network of ... Canada to offer assistance in application use, ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. ... the largest retail drugstore chain in China based on ... unaudited financial results for the first quarter ended March ... ended March 31, 2011: Revenue increased by ...
... 24, 2011 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... commercialization of products for central nervous system disorders, today announced ... on Thursday, June 16, 2011, in Rockville, Maryland.  The record ... stockholders of record as of the close of business on ...
Cached Medicine Technology:China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 2China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 3China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 4China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 5China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 6China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 7China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 8China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 9
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
(Date:4/17/2014)... MD, was recently invited to submit a review ... Microbiology , one of the world,s foremost scientific ... specialist, and chair of the Department of Pediatrics ... analyzed the epidemiology and microbiology of co-infections during ... as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... , , ORLANDO, Fla., ... new report today at its annual convention in Toronto acknowledging ... comes to dealing with conflicts between religious beliefs and same-sex ... conflict with their sexuality and faith, says this report acknowledges ...
... ... , ... Atlanta, GA (Vocus) August 5, 2009 -- CareFirst BlueCross BlueShield (CareFirst) today announced that ... in National Account Service Company LLC (NASCO), joining the Blue Cross and Blue Shield ...
... , , BOSTON, Aug. 5 ... management solutions, today reported unaudited financial results for the second quarter ended June ... ) , , Q2 Financial Highlights ... second quarter of 2009 was $23.5 million, compared to $13.6 million for the ...
... , , HARRISBURG, Pa., Aug. ... of Massage Therapy began drafting preliminary regulations that will protect ... Commonwealth Pedro A. Cortes. , , "By ... and training, we can provide the best and most up-to-date ...
... , , ST. PAUL, Minn., Aug. ... Extreme Makeover: Home Edition (EMHE) premieres its seventh season ... be among a select group as a Designated Charity for an ... Duluth/Superior area. The EMHE episode, air date to be announced at ...
... simply a marker for obesity is unclear , , WEDNESDAY, ... activates sex hormones throughout the body may also predict those ... study finds. , The protein, called sex hormone-binding globulin (SHBG), ... Researchers suspect it also plays a role in the development ...
Cached Medicine News:Health News:APA Releases Report on Sexuality Debate 2Health News:APA Releases Report on Sexuality Debate 3Health News:CareFirst Joins Partnership of Blues Plans as Owner of NASCO 2Health News:CareFirst Joins Partnership of Blues Plans as Owner of NASCO 3Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 2Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 3Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 4Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 5Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 6Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 7Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 8Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 9Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 10Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 11Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 12Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 13Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 14Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 15Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 16Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 17Health News:State Regulation of Massage Therapy Will Improve Public Health, Safety 2Health News:State Regulation of Massage Therapy Will Improve Public Health, Safety 3Health News:Memorial Blood Centers Joins Extreme Makeover: Home Edition As Designated Charity 2Health News:Memorial Blood Centers Joins Extreme Makeover: Home Edition As Designated Charity 3Health News:Sex Hormone Protein May Predict Type 2 Diabetes 2Health News:Sex Hormone Protein May Predict Type 2 Diabetes 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: